Intervention
Anti-Thymocyte Globulin
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 6 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
6 shownUmbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or LymphomaNCT03096782 · 2017-10-13
COMPLETEDOmental Islet TransplantNCT02821026 · 2016-05-01
COMPLETEDScleroderma Treatment With Autologous Transplant (STAT) StudyNCT01413100 · 2011-09-15
COMPLETEDAllogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast CancerNCT01375023 · 2009-06-01
TERMINATEDAutologous Stem Cell Transplant for Neurologic Autoimmune DiseasesNCT00716066 · 2008-06-01
ACTIVE_NOT_RECRUITINGStudy of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas TransplantationNCT00331162 · 2005-02-01
COMPLETEDCommon conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive1Acute Biphenotypic Leukemia1Acute Leukemia1Acute Lymphoblastic Leukemia1Acute Lymphoblastic Leukemia in Remission1Acute Myeloid Leukemia1Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome1Autoimmune Disease1Autoimmune Nervous System Disorder1Autologous Transplant Autoimmune1Breast Cancer1Central Nervous System Vasculitis1Cerebellar Degeneration1Chemotherapy-Related Leukemia1Chronic Inflammatory Demyelinating Polyneuropathy1Chronic Lymphocytic Leukemia1Chronic Myelogenous Leukemia, BCR-ABL1 Positive1Chronic Myelomonocytic Leukemia1CIDP Transplant1Graft Rejection1HCT for Neurologic Autoimmune Disorders1Hodgkin Lymphoma1Lambert Eaton Myasthenic Syndrome1Langerhans Cell Histiocytosis1Minimal Residual Disease1
Leading sponsors
Trial status mix
COMPLETED4
ACTIVE_NOT_RECRUITING1
TERMINATED1
Phase mix
PHASE25
PHASE11
PHASE41
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.